Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
During the past several years, there has been a perceived drug safety crisis in the United States. The Institute of Medicine (IOM), recently released its final recommendations for reforming the U.S. drug safety system, but an editorial published in Health Economics by Tomas Philipson and colleagues at the University of Chicago finds little evidence of a drug safety crisis and no scientific evidence to back up the IOM’s recommendations.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company?s Abbreviated New Drug Application (ANDA) for Rabeprazole Sodium Delayed-Release Tablets, 20 mg.
Pfizer Inc said that a Danish court has granted a preliminary injunction against Nomeco A/S — the largest pharmaceutical wholesaler in Denmark — that prohibits the sale of a generic version of Lipitor by generics manufacturer Ranbaxy.
In UK increasing numbers of gay men are requesting a vaccine – HPV vaccine – which protects against a sexually transmitted infection that can cause cervical, penile and anal cancers, reported by Cancer Research UK.
African scientists will soon begin training at Emory University as part of a unique partnership between Emory and the Republic of South Africa. The South Africa Drug Discovery Training Program will address the rising dangers of diseases that unduly affect developing countries.
University of Minnesota researchers have discovered a variant of a common blood protein, apolipoprotein C1, in people of American Indian and Mexican ancestry that is linked to elevated body mass index (BMI), obesity and Type 2 diabetes.
The Office of Fair Trading (OFT) market study has today recommended a fundamental reform of the drug pricing system in the UK, which would see the current profit and price controls replaced with a value-based approach to pricing.
The OFT today recommended that the Pharmaceutical Price Regulation Scheme ( PPRS ) should be reformed, to deliver better value for money from NHS drug spend and to focus business investment on drugs that have the greatest benefits for patients.